Conclusion The clinical implications of prostate cancer greatly depend on early detection, which is primarily achieved through preventive services. Unfortunately, men with average risk of developing prostate cancer have to weigh the risk and benefits of screening. An advanced practice nurse should follow the USPSTF screening guidelines when trying to determine if PSA is right for their patient.
References American Cancer Society. (2017). Key Statistics for Prostate Cancer. Retrieved from Arcangelo, V. P., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins. Center for Disease Control and Prevention [CDC], (2014). Prostate Cancer Rates by Race and Ethnicity. Retrieved from McGinley, K. F., McMahon, G. C., & Brown, G. A. (2015). Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Group Practice Following Statement Revision. Reviews In Urology , 17 (3), 171-177. Retrieved from Walden Library databases. National Cancer Institute . (2011). Treatment Choices for Men with Early-Stage Prostate Cancer. Retrieved from - treatment- choices.pdf U.S. Preventative Services Task Force [USPSTF]. (2014). The Guide to Clinical Preventative Services:Recommendations for Adults. Retrieved from - better-preventive-care
- Summer '15
- Prostate cancer, Prostate-specific antigen